April 2010- Volume 6, Issue 4

April 2010

In this Issue

Contract Services

Clinical research gets a boost

Clinical research gets a boost

invivodata’s regulatory expertise enhances INC Research’s global service offering

French say ‘oui’ to U.K.’s NextPharma

French say ‘oui’ to U.K.’s NextPharma

Ministry of Research approves company as a contract research and development organization; French clients can now claim tax credits

Eyes on Europe

Eyes on Europe

AMRI expands geographic footprint and market share across the pond with Excelsyn acquisition

They’re certifiable … in a good way

They’re certifiable … in a good way

BioClinica teams with two additional CROs to strengthen its Certified Partner Program

Instruments & Informatics

Supercomputing, one PC at a time

Supercomputing, one PC at a time

Scripps uses IBM World Community Grid to achieve some breakthrough work on HIV/AIDS

Computype & Agilent: Linked by labels

Computype & Agilent: Linked by labels

Computype partners with Agilent Technologies on launch of new microplate labeler, and with Biosero on storage tube label applicators

ALA and SBS propose to merge as SLAS

ALA and SBS propose to merge as SLAS

Two top associations seek enhanced opportunities for members, greater global reach and financial and operational efficiencies

Research & Development

Out of left field

Out of left field

Merck KGaA to acquire Millipore for $7.2 billion

Multi-faceted deal

Multi-faceted deal

Abbott expands pipeline with $450 million Facet Biotech acquisition

Pain- busting partnership

Pain- busting partnership

BMS and Allergan in $413 million deal to develop drug for neuropathic pain

Small molecules lead to big partnership

Small molecules lead to big partnership

UCSF enters into drug discovery agreement with Roche’s Genentech

One door closes, and another opens

One door closes, and another opens

MDS divests Pharma Services business to Ricerca Biosciences

Breathing easier

Breathing easier

Cephalon’s purchase of Ception to further asthma control research

Global News

Awkward courtship

Awkward courtship

After more than a year of wooing OSI unsuccessfully, Astellas goes for hostile bid

From North Carolina to Norway

From North Carolina to Norway

The Hamner Institutes for Health Sciences and Oslo Cancer Cluster announce oncology-based partnership

The art of collaboration

The art of collaboration

WuXi reaches agreement with J&J Pharmaceutical Research & Development

Epigenetics evolves in international partnership

Epigenetics evolves in international partnership

CellCentric licenses novel epigenetic discovery program to Takeda

Enough with the labels

Enough with the labels

Tecan and ForteBio automate label-free assays for bioprocess and drug discovery applications

Omics & Systems Biology

Done deal for drug discovery

Done deal for drug discovery

Asterand completes acquisition of BioSeek, a developer of cell-based disease models

Companions in companion diagnostics

Companions in companion diagnostics

Roche Molecular Systems collaborates with Merck Sharp & Dohme on developmental test for cancer-related gene mutation

Liver on their plates

Liver on their plates

Regulus, GSK to develop HCV therapies

Feature

AACR’s Capitol idea

AACR’s Capitol idea

American Association for Cancer Research’s annual conference for 2010 heads to the nation’s capital and offers some new features

Diagnostics

Stanford health experts help develop North Korea’s first drug-resistant tuberculosis diagnostic lab

Stanford health experts help develop North Korea’s first drug-resistant tuberculosis diagnostic lab

Stanford University professors have broken new ground by trekking through North Korea to initiate the installation of a diagnostic lab to test drug-resistant tuberculosis

Seeking immunosimplicity

Seeking immunosimplicity

Diamedix inks distribution pact with Fumouze Diagnostics

Seeing green with a hybrid

Seeing green with a hybrid

Quidel Corp. completes $130 million acquisition of Diagnostic Hybrids

Mining for melanoma

Mining for melanoma

GSK, Abbott partner on molecular diagnostic test to select candidates for skin cancer immunotherapy

Commentary

Minimizing the cost effects of false positives in cancer testing

Minimizing the cost effects of false positives in cancer testing

In recent months, controversy has swirled around the proper age at which women should have their first mammograms and Pap smears. Yet even as these questions dominate the headlines, we ought not lose sight of a larger issue that affects the lives of every potential cancer patient, male and female: the emotional and economical costs associated with false positives in cancer testing.

Primer on boards of directors

Primer on boards of directors

Do you know what the board is doing? Does the board know what you are doing?

Editor's Focus

March marked by many mergers and acquisitions

March marked by many mergers and acquisitions

Our special “March M&A Madness!” cover highlights a busy month of mergers and acquisitions in the pharmaceutical and biotechnology industries.
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

November 2022 Issue Front Cover

Latest Issue  

• Volume 18 • Issue 11 • November 2022

November 2022

November 2022